Cargando…

Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors

SIMPLE SUMMARY: Neoplastic processes are accompanied by the reprogramming of cell metabolism and alteration of the balance between endogenous bioregulators with signaling functions. Prostanoid signaling is a part of the global arachidonic acid pathway and is associated with cancer progression. It in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ershov, Pavel V., Yablokov, Evgeniy O., Kaluzhskiy, Leonid A., Mezentsev, Yuri V., Ivanov, Alexis S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029281/ https://www.ncbi.nlm.nih.gov/pubmed/35453789 http://dx.doi.org/10.3390/biology11040590

Ejemplares similares

Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context
por: Ershov, Pavel, et al.
Publicado: (2021)

SPR Biosensors in Direct Molecular Fishing: Implications for Protein Interactomics
por: Florinskaya, Anna, et al.
Publicado: (2018)

Protein Interactome Profiling of Stable Molecular Complexes in Biomaterial Lysate
por: Mezentsev, Yuri, et al.
Publicado: (2022)

Uncharacterized Proteins CxORFx: Subinteractome Analysis and Prognostic Significance in Cancers
por: Ershov, Pavel, et al.
Publicado: (2023)

Mechanism of the Affinity-Enhancing Effect of Isatin on Human Ferrochelatase and Adrenodoxin Reductase Complex Formation: Implication for Protein Interactome Regulation
por: Ershov, Pavel V., et al.
Publicado: (2020)

Affinity Isolation and Mass Spectrometry Identification of Prostacyclin Synthase (PTGIS) Subinteractome
por: Ershov, Pavel V., et al.
Publicado: (2019)

Human Lanosterol 14-Alpha Demethylase (CYP51A1) Is a Putative Target for Natural Flavonoid Luteolin 7,3′-Disulfate
por: Kaluzhskiy, Leonid, et al.
Publicado: (2021)

Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions
por: Ershov, Pavel V., et al.
Publicado: (2022)

Molecular Cloning, Heterologous Expression, Purification, and Evaluation of Protein–Ligand Interactions of CYP51 of Candida krusei Azole-Resistant Fungal Strain
por: Tsybruk, Tatsiana V., et al.
Publicado: (2023)

Direct Molecular Fishing of New Protein Partners for Human Thromboxane Synthase
por: Svirid, A. V., et al.
Publicado: (2017)

Comprehensive expression analysis of prostanoid enzymes and receptors in the human endometrium across the menstrual cycle
por: Catalano, Rob D., et al.
Publicado: (2011)

SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
por: Ershov, P. V., et al.
Publicado: (2023)

Physiology and pathophysiology of prostanoid receptors
por: Narumiya, Shuh
Publicado: (2007)

The Immunobiology of Prostanoid Receptor Signaling in Connecting Innate and Adaptive Immunity
por: Harizi, Hedi
Publicado: (2013)

The role of thromboxane prostanoid receptor signaling in gastric ulcer healing
por: Yamane, Sakiko, et al.
Publicado: (2021)

Prostanoid Receptors in the Human Vascular Wall
por: Norel, Xavier
Publicado: (2007)

Prostanoid Receptors Involved in Regulation of the Beating Rate of Neonatal Rat Cardiomyocytes
por: Mechiche, Hakima, et al.
Publicado: (2012)

Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors
por: Sharif, Najam A.
Publicado: (2022)

Complex Role for E‐Prostanoid 4 Receptors in Hypertension
por: Herrera, Marcela, et al.
Publicado: (2019)

Epoxyeicosatrienoic Acid and Prostanoid Crosstalk at the Receptor and Intracellular Signaling Levels to Maintain Vascular Tone
por: Malacarne, Pedro Felipe, et al.
Publicado: (2022)

Prostanoid Receptor Subtypes and Its Endogenous Ligands with Processing Enzymes within Various Types of Inflammatory Joint Diseases
por: Al-Madol, Mohammed A., et al.
Publicado: (2020)

Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide
por: Bonfill-Teixidor, Ester, et al.
Publicado: (2017)

Activation of the signaling cascade in response to T lymphocyte receptor stimulation and prostanoids in a case of cutaneous lupus
por: Abreu-Velez, Ana Maria, et al.
Publicado: (2011)

The D-type prostanoid (DP) receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)
por: Sedej, Miriam, et al.
Publicado: (2011)

Expression of Prostanoid EP3 Receptors in Oral Squamous Epithelium and Oral Squamous Cell Carcinoma
por: Kashif, Muhammad, et al.
Publicado: (2015)

Expression of E-prostanoid receptors in nasal polyp tissues of smoking and nonsmoking patients with chronic rhinosinusitis
por: Xie, Li, et al.
Publicado: (2018)

E-type prostanoid receptor 4 (EP4) in disease and therapy
por: Konya, Viktoria, et al.
Publicado: (2013)

Contribution of prostanoid FP receptor and prostaglandins in transient inflammatory ocular hypertension
por: Yamagishi-Kimura, Reiko, et al.
Publicado: (2018)

Improved homology modeling of the human & rat EP(4) prostanoid receptors
por: Holt, Melissa C., et al.
Publicado: (2019)

Prostanoid Metabolites as Biomarkers in Human Disease
por: Idborg, Helena, et al.
Publicado: (2022)

The Link between Prostanoids and Cardiovascular Diseases
por: Beccacece, Livia, et al.
Publicado: (2023)

EP4-mediated prostanoid signalling promotes oral cancer progression
por: Sapienza, Karen, et al.
Publicado: (2010)

Significance of Pulmonary Endothelial Injury and the Role of Cyclooxygenase-2 and Prostanoid Signaling
por: Nickl, Rosa, et al.
Publicado: (2023)

Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo
por: Kozlovskiy, Sergei, et al.
Publicado: (2023)

Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation
por: Philipose, Sonia, et al.
Publicado: (2012)

Inverse Agonist and Pharmacochaperone Properties of MK-0524 on the Prostanoid DP1 Receptor
por: Labrecque, Pascale, et al.
Publicado: (2013)

Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
por: Philipose, Sonia, et al.
Publicado: (2012)

Antagonism of the Thromboxane‐Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy
por: West, James D., et al.
Publicado: (2019)

Anti-Inflammatory Prostanoids: Focus on the Interactions between Electrophile Signaling and Resolution of Inflammation
por: Díez-Dacal, Beatriz, et al.
Publicado: (2010)

Prostanoid therapies in the management of pulmonary arterial hypertension
por: LeVarge, Barbara L
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dsipi4ba1o16f0s3u6ve4ip93f